Riskpilot← Back to searchSign inGet full accessNÅLØYE AS
ASActiveOrg 916158564Kjelsåsveien 32A, 0488 OsloTraditional, complementary and alternative medicine activities · NACE 8696Est. 20151 employeesnåløyeklinikken.no
Revenue 2024
NOK 266K
-19% vs 2023
EBITDA margin
-18.5%
-90% vs 2023
Equity ratio
-1646.5%
Financial strength
Net profit 2024
NOK -51K
-89% vs 2023
| Revenue | NOK 266K | -19% |
| EBITDA | NOK -49K | -90% |
| Net profit | NOK -51K | -89% |
| Total assets | NOK 8K | -57% |
| Equity | NOK -139K | -58% |
| Employees | 1 | — |
Legal name
NÅLØYE AS
Org number
916158564
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
2. november 2015
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Mirja luukkonen
Company purpose
Levere tjenester innen akupunktur, massasjeterapi og kinesiologi samt andre tjenester/produkter som naturlig faller sammen med dette, herunder delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Kjelsåsveien 32A, 0488 Oslo
Website
nåløyeklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 550 | 587 | 394 | 328 | 266 |
| Staff expenses | −280 | −349 | −199 | −111 | −115 |
| EBITDA | −25 | −43 | −77 | −26 | −49 |
| Depreciation & amort. | −0 | −4 | −6 | −6 | −2 |
| EBIT | −25 | −47 | −83 | −32 | −51 |
| Net financials | 38 | 23 | 21 | 5 | 0 |
| Profit before tax | 13 | −24 | −62 | −27 | −51 |
| Tax | 6 | −13 | −0 | −0 | −0 |
| Net profit | 7 | −11 | −62 | −27 | −51 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 64 | 66 | 101 | 20 | 8 |
| Equity | 12 | 1 | −61 | −88 | −139 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 51 | 65 | 161 | 107 | 147 |
| Total debt | 51 | 65 | 161 | 107 | 147 |
EBITDA margin
-18.5%
This company
15.8%
Market median
-217% vs market
20202024
Equity ratio
-1646.5%
This company
38.2%
Market median
-4410% vs market
20202024
Return on equity
-5116000.0%
This company
18.4%
Market median
-27804448% vs market
20202024
Net profit margin
-19.2%
This company
8.1%
Market median
-337% vs market
20202024
Asset turnover
31.57×
This company
1.12×
Market median
+2719% vs market
20202024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
MR Chief Executive Officer | Chief Executive Officer | 2015 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (2) | ||
| Chairman | 2015 – 2023 | |
| Board of Directors | 2015 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NÅLØYE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marius Ryan | Chief Executive Officer | 0 companies |
| Mirja Luukkonen | Chairman | 0 companies |
| Terje Unnerud | Chairman | 0 companies |
| Inger Lene Brovold | Board of Directors | 0 companies |